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Na 137 134 137 138 136
K 3.9 4.0 3.9 4.0 3.9
Crea 0.91 1.10 1.10 0.97 1.07
TP 7.9 7.2 6.7 6.9 7.1
Albumin 3.6 3.0 3.0 2.6 2.6
Total Bil. 6.8 25.3 25.0 22.3 23.1
Direct Bil. 22.2 21.0 19.4
AST 94 81 79 74 75
ALT 217 67 68 62 63






A 31-year-old male without significant past medical history presented initially 
to the emergency department with nausea and vomiting. He was found to 
be jaundiced with a total bilirubin level of 6.3 mg/dl and elevated liver 
enzymes with AST 94 U/L, ALT 217 U/L with normal ALP 85 U/L. His 
condition was stable, and he was discharged with a recommendation to 
follow up as an outpatient with gastroenterology. However, 3 weeks later,  
the patient presented to the emergency department again due to weight  
loss and severe pruritus. Labs were notable for worsening bilirubin level of  
25 mg/dl with ALP of 274 U/L, AST 81 U/L and ALT 67 U/L. He denied fever, 
abdominal pain, nausea, vomiting, or diarrhea. He reported social alcohol 
use with his last drink over a month ago. He did admit to starting a new 
workout supplement “Xtreme DMZ” about 3 months prior. He had a negative 
serologic workup for liver disease including viral hepatitis and autoimmune 
hepatitis. Radiological imaging of the abdomen including ultrasound and  
CT scan were unrevealing. The patient was diagnosed with a drug-induced 
liver injury secondary to dymethazine, an anabolic prohormone present in 
“Xtreme DMZ”. As for treatment for severe pruritus, he required atarax, 
questran, and rifampin which eventually improved his symptoms. 
Discussion
17-beta-hydroxy 2-alpha, 17-beta-dimethyl 5-aIpha-androstan 3-on azine 
also known as dymethazine is an anabolic prohormone that is rising in 
popularity amongst bodybuilders. It has been shown to promote muscular 
hypertrophy and is advertised as safe with few side effects. Similarly, to 
many other anabolic supplements, it is not controlled by FDA. This case 
highlights how anabolic prohormones such as dymethazine, as seen in 
“Xtreme DMZ”, can cause cholestatic liver injury. Other case reports have 
shown similar clinical symptoms and pattern of liver injury. The purpose of 
this report is to familiarize physicians with the dangerous side effects of 
nutritional supplements containing anabolic prohormones.
Dietary supplements are widely 
popular, especially those used as 
workout supplements. Though  
many people can tolerate them 
without significant side effects,  
they have been shown to cause 
serious liver injury and even failure.
This case highlights the risk of  
these supplements in a young male 
who developed jaundice after  
the use of “Xtreme DMZ”. 
